Clinical Trial Update: A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients [Phase 3]

View source ↗

Summary

This entry reports the completion of a Phase 3 study evaluating an investigational medication for secondary hyperparathyroidism in patients on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperparathyroidism

Drugs mentioned

• Investigational medication

Snippet

Sponsor: Amgen | Conditions: Secondary Hyperparathyroidism, End Stage Renal Disease | Phase 3 | Status: COMPLETED